Dudediligence.

TuHURA Biosciences, Inc

HURANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.6MSep ’24−$6.0MDec ’24−$6.7MMar ’25−$9.5MJun ’25−$7.1MSep ’25−$7.7MDec ’25−$7.5MMar ’26−$9.2MJun ’26
Fiscal years, by the month each ended
LineJun 2022Dec 2023Dec 2024Dec 2025Jun 2026
Revenuenone on file$0.00$0.00$0.00none on file
Net income−$22.7M−$29.3M−$21.7M−$31.0Mnone on file
Operating cash flow−$20.4M−$12.0M−$14.7M−$27.6Mnone on file
Free cash flownone on file−$12.0M−$14.8M−$27.7Mnone on file
Cash$11.8M$3.7M$12.7M$3.6M$995,977
Debtnone on filenone on filenone on filenone on file$3.6M
Shares outstanding1.3M12.2M12.2M59.3M63.7M